Clinical Trial: A Study to Evaluate ALN-AGT01 RVR in Adult Patients With Mild to Moderate Hypertension Pretreated With Zilebesiran

U.S., April 29 -- ClinicalTrials.gov registry received information related to the study (NCT07553442) titled 'A Study to Evaluate ALN-AGT01 RVR in Adult Patients With Mild to Moderate Hypertension Pretreated With Zilebesiran' on April 22.

Brief Summary: The purpose of this study is to evaluate the efficacy, pharmacodynamics (PD), and safety of ALN-AGT01 RVR in participants with mild to moderate hypertension pretreated with zilebesiran.

Study Start Date: April 27

Study Type: INTERVENTIONAL

Condition: Hypertension

Intervention: DRUG: ALN-AGT01 RVR

ALN-AGT01 RVR will be administered subcutaneously (SC)

DRUG: Placebo

Placebo will be administered SC

DRUG: Zilebesiran

Zilebesiran will be administered SC

Recruitment Status: NOT_YET_RE...